Geyskes G G, Stutterheim A, Boer P, Mees E J
Eur J Clin Pharmacol. 1975 Dec 19;9(2-3):85-90. doi: 10.1007/BF00614001.
A double blind cross-over trial of fixed doses of propranolol (640 mg/day) and the cardioselective drug practolol (1600 mg/day) was performed in 28 patients with essential hypertension whose blood pressure was not adequately controlled by chlorthalidone (100 mg 3 times weekly) alone. Chlorthalidone alone was given during the first (control) period, and it was continued throughout the propranolol and practolol treatment periods, each of 10 weeks. The systolic and diastolic blood pressures were lowered significantly by both the beta blocking drugs. The changes in blood pressure caused by altering the patient's position were the same after both beta blockers. Propranolol produced slightly lower values than practolol, but the difference was significant only for diastolic blood pressure in the sitting and supine positions. In individual patients the final blood pressure after propranolol was correlated with the final blood pressure after practolol. Only minimal side-effects of either drug were noticed. It is concluded that the doses employed both of propranolol and practolol had a good and approximately equal antihypertensive effect when combined with chlorthalidone treatment. There was no correlation between the final blood pressure and plasma renin activity.
对28例原发性高血压患者进行了一项双盲交叉试验,这些患者单独使用氯噻酮(每周3次,每次100mg)时血压控制不佳。试验中固定剂量的普萘洛尔(640mg/天)和心脏选择性药物醋丁洛尔(1600mg/天)。在第一个(对照)阶段单独给予氯噻酮,并在整个普萘洛尔和醋丁洛尔治疗阶段持续使用,每个治疗阶段为10周。两种β受体阻滞剂均能显著降低收缩压和舒张压。两种β受体阻滞剂治疗后,改变患者体位引起的血压变化相同。普萘洛尔产生的值略低于醋丁洛尔,但仅在坐位和仰卧位舒张压方面差异有统计学意义。在个体患者中,普萘洛尔治疗后的最终血压与醋丁洛尔治疗后的最终血压相关。两种药物均仅观察到极少的副作用。得出的结论是,普萘洛尔和醋丁洛尔与氯噻酮联合治疗时,所用剂量均具有良好且大致相等的降压效果。最终血压与血浆肾素活性之间无相关性。